Join the club for FREE to access the whole archive and other member benefits.

AI startup Inceptive to use $100M funding for novel medicines

Developing "biological software" for effective and affordable mRNA drug design


Key points from article :

Inceptive, a Californian AI startup, secures $100M funding to advance its mRNA-based medicine design platform.

The company uses AI to design novel medicines previously out of reach.

Their goal is to offer this platform to organizations involved in the development of mRNA and RNA medicines.

The funding will enhance the capabilities of Inceptive's "biological software" platform.

Over 310 programs are in progress between pre-clinical and clinical trials.

Inceptive's co-founder aims to provide this as a horizontal capability to any entity developing mRNA and later RNA medicines.

Mentioned in this article:

Click on resource name for more details.


Developing tools for advanced, accessible biological software design

Topics mentioned on this page:
Investments, AI in Healthcare
AI startup Inceptive to use $100M funding for novel medicines